Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study.

Madsen, Christian M

Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study. [electronic resource] - Arteriosclerosis, thrombosis, and vascular biology 01 2020 - 255-266 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1524-4636

10.1161/ATVBAHA.119.312951 doi


Adult
Aged
Cardiovascular Diseases--blood
Denmark--epidemiology
Female
Follow-Up Studies
Humans
Hypolipidemic Agents--therapeutic use
Lipoprotein(a)--blood
Male
Middle Aged
Morbidity--trends
Population Surveillance--methods
Prognosis
Retrospective Studies
Risk Factors
Secondary Prevention--methods
Time Factors
Young Adult